Skip to content

Gilead Sciences GILD Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Gross margin315.4%+7.1pp314.4%+8.5pp313.8%+10.2pp311.2%+4.8pp308.4%-1.7pp
Operating margin132.9%+86.4pp126.6%+103pp98.3%+52.5pp65.2%-8.0pp46.5%-48.4pp
Net margin109.6%+83.0pp99.4%+91.7pp72.2%+45.3pp44.7%-3.1pp26.7%-37.5pp
Returns
Return on equity157.5%+117pp146.8%+136pp108.6%+74.4pp68.7%+8.0pp40.7%-41.0pp
Return on invested capital86.7%+58.7pp82.3%+71.7pp63%+40.5pp41.6%+4.5pp27.9%-20.1pp
Efficiency
Asset turnover2.1×+0.1×2.1×+0.1×+0.2×+0.2×1.9×+0.2×
Liquidity
Current ratio6.3×+0.9×5.7×+0.6×5.7×+0.8×5.5×+0.6×5.4×+0.5×
Leverage
Debt-to-equity4.5×-0.8×4.9×-0.5×5.1×0.0×5.2×+0.3×5.3×+0.4×
Net debt / EBITDA7.1×-24.4×7.7×-28.4×14.4×-15.2×28×+11.7×31.5×+19.2×
Per Share
Book value per share$69.70+16.2%$66.16+12.5%$63.48+3.1%$61.03-5.5%$59.97-10.2%
Valuation
Market capitalization$596.35B+34.1%$563.05B+42.1%$525.88B+37.6%$492.53B+32.7%$444.66B+16.5%
Price / earnings74.8×-1,098×79.4×-1,259×301.4×-815×1,112.8×+809×1,172.8×+933×
Price / sales20.3×+4.7×19.4×+5.3×18.2×+4.4×17.2×+3.6×15.6×+1.7×
Price / book27.2×+3.7×27.2×+5.7×26.4×+6.5×25.7×+7.2×23.6×+5.2×
EV / EBITDA66.3×-149×67.1×-166×115.5×-65.0×203.5×+114×215.4×+145×
Dividend yield10.8%-3.6pp11.3%-4.5pp12.1%-4.1pp12.9%-3.6pp14.5%-1.5pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Gilead Sciences's profit margins?
Gilead Sciences (GILD) runs a 79.4% gross margin and a 34.9% operating margin, with a 31.0% net margin.
Where do Gilead Sciences's ratios come from?
Every ratio is computed from Gilead Sciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.